The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors

Radiation Research

Volumn 179, Issue 1, 2013, Pages 46-52

  Sera, Nobuko ^a   Hida, Ayumi ^a   Imaizumi, Misa ^a   Nakashima, Eiji ^a   Akahoshi, Masazumi ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATOMIC BOMB SURVIVOR; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; KIDNEY; MALE; METABOLIC SYNDROME X; NUCLEAR WEAPONS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVORS;

EID: 84872118701     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2863.1     Document Type: Article

References (41)

1. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992; 69:1241-7.
2. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999; 43:755-62.
3. Cheng SW, Ting AC, Lam LK, Wei WI. Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2000; 126:517-21. (Pubitemid 30207365)
4. Berrington A, Darby SC, Weiss HA, Doll R. 100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol 2001; 74:507-19. (Pubitemid 32674212)
5. Darby SC, Doll R, Gill SK, Smith PG. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987; 55:179-90. (Pubitemid 17021681)
6. Carr ZA, Land CE, Kleinerman RA, Weinstock RW, Stovall M, Griem ML, et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 2005; 61:842-50. (Pubitemid 40247980)
7. Sasaki H, Wong FL, Yamada M, Kodama K. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J Clin Epidemiol 2002; 55:974-81. (Pubitemid 36018861)
8. Katsuda S, Hasegawa M, Kusanagi M, Shimizu T. Comparison of pulse-wave velocity in different aortic regions in relation to the extent and severity of atherosclerosis between young and older Kurosawa and Kusanagi- hypercholesterolemic (KHC) rabbits. Clin Sci 2000; 99:393-404.
9. Yamada M, Naito K, Kasagi F, Masunari N, Suzuki G. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study. Int J Radiat Biol 2005; 81:821-6. (Pubitemid 43244601)
10. Minamoto A, Taniguchi H, Yoshitani N, Mukai S, Yokoyama T, Kumagami T, et al. Cataract in atomic bomb survivors. Int J Radiat Biol 2004; 80:339-45. (Pubitemid 38943095)
11. Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res 1999;151:736-46. (Pubitemid 29252562)
12. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 2004; 161:622-32. (Pubitemid 39149570)
13. Akahoshi M, Amasaki Y, Soda M, Hida A, Imaizumi M, Nakashima E, et al. Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens Res 2003; 26:965-70. (Pubitemid 38128769)
14. Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int J Radiat Biol 2003; 79:129-36. (Pubitemid 36183071)
15. Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F, et al. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med 2005; 118:83-6. (Pubitemid 40082463)
16. Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, et al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens Res 2001; 24:337-43. (Pubitemid 32791809)
17. Baba T, Amasaki Y, Soda M, Hida A, Imaizumi M, Ichimaru S, et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res 2007; 30:823-9. (Pubitemid 47578244)
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-266.
19. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-305.
20. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13:745-53. (Pubitemid 34183941)
21. Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007; 30:937-43. (Pubitemid 350120971)
22. Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006; 48:383-91. (Pubitemid 44247252)
23. Commission ABC. Research plan for joint ABCC-NIH Adult Health Study in Hiroshoima and Nagasaki in ABCC. Technical Reports; 1962. P. 11-62.
24. Seino YN, Tajima N, Kadowaki N, Kashiwagi A, Araki E, Ito C, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int; 2010.
25. Young RK, G. . Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki-Dosimetry System 2002. Hiroshima: Radiation Effects Research Foundation. 2005.
26. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 1990; 123:275-84. (Pubitemid 20327898)
27. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-92.
28. Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for the diagnosis of metabolic syndrome. J Jpn Soc Int Med 2005; 94:794-809.
29. Espinola-Klein C, Rupprecht HJ, Bickel C, Lackner K, Savvidis S, Messow CM, et al. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation 2008; 118:961-7.
30. Dogra G, Irish A, Chan D, Watts G. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 2006; 48:926-34. (Pubitemid 44895366)
31. Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45:494-501.
32. Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2006; 69:350-7. (Pubitemid 43323087)
33. Schillaci G, Pirro M, Mannarino MR, Pucci G, Savarese G, Franklin SS, et al. Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension 2006; 48:616-21. (Pubitemid 44843864)
34. Peralta CA, Katz R, Madero M, Sarnak M, Kramer H, Criqui MH, et al. The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis. Am J Epidemiol 2009; 169:740-8.
35. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43:1318-23. (Pubitemid 38691756)
36. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-5. (Pubitemid 32472900)
37. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002; 87:2764-9. (Pubitemid 34655342)
38. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism 2004; 53:589-93. (Pubitemid 38596530)
39. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005; 54:476-81. (Pubitemid 40410448)
40. Tentolouris N, Doulgerakis D, Moyssakis I, Kyriaki D, Makrilakis K, Kosmadakis G, et al. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. Horm Metab Res 2004; 36:721-7. (Pubitemid 39486974)
41. Fakhouri F, La Batide Alanore A, Rerolle JP, Guery B, Raynaud A, Plouin PF. Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis. Am J Kidney Dis 2001; 38:302-9.